搜尋結果
6 天前 · Key statistics. On Tuesday, CARsgen Therapeutics Holdings Ltd (2171:HKG) closed at 6.62, 77.48% above the 52 week low of 3.73 set on Jan 31, 2024. Data delayed at least 15 minutes, as of May 21 2024 09:08 BST. All markets data located on FT.com is subject to the FT Terms & Conditions. All content on FT.com is for your general information and ...
CARsgen Therapeutics Holdings Limited (2171.HK) Add to watchlist HKSE - HKSE Delayed Price. Currency in HKD 6.550 +0.450 (+7.38%) At close: 04:08PM HKT Add Comparison Indicators Technicals ...
2021年6月19日 · View real-time 2171 stock price and news, along with industry-best analysis. Explore Our Brands WSJ ... HK$3.44B Shares Outstanding 575.64M EPS (TTM)-HK$1.49 P/E Ratio (TTM)N/A Dividend Yield N/A ...
2024年3月28日 · CARsgen Therapeutics Holdings Ltd (2171:HKG) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally ...
2022年3月23日 · 科济药业(股票代码：2171.HK)是一家在中国及美国拥有业务的生物制药公司，主要专注于治疗血液恶性肿瘤和实体瘤的创新CAR-T细胞疗法。 我们建立了一个综合细胞治疗平台，其内部能力涵盖从靶点发现、抗体开发、临床试验到商业规模生产。
Home -. About CARsgen. We focus on innovative CAR T-cell therapies. We are a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematological malignancies and solid tumors. Read More.
